Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Real World Evidence/RWE Solutions Market Size study, By Component (Services, Data Sets, Clinical setting data, Claims data, Pharmacy data, Patient powered data), By Therapeutic area (Oncology, Cardiovascular, Neurology, Immunology, Others), By End Users (Pharmaceutical and Medical Devices Companies, Healthcare Providers, Healthcare Payers, Other End Users), and Regional Forecasts 2022-2028

  • BIZ4950349
  • 200 Pages
  • February 2022
  • Healthcare
Download Sample    Get Discount   
 
Global Real World Evidence/RWE Solutions Market is valued approximately USD 1.03 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.6% over the forecast period 2022-2028. Real World Evidence in medicine refers to the evidences that are collected from real world data, which is a factual data acquire from outside controlled trials and produced through routine clinical practice. RWD creates extrapolative results, insights, prudence on diseases, unmet patient needs, medical devices, and the value provided by the goods to patient demographics and sub-populations as per the observational data. RWE offers data about various areas such as effectiveness studies, course of disease & natural history, outcome study, and safety surveillance. The growing support of the governments for the penetration of RWE solutions, the growing prevalence of chronic diseases, the rising geriatric population, coupled with the increasing R&D investments is the primary factors that may augment the market demand across the globe. For instance, in May 2021, Five RWD and analytics organizations that is Aetion, Flatiron Health, IQVIA, Syapse, and Tempus come into an industry association with the objective of advance the usage of RWE solutions to support governmental decisions. Thereby, an increasing number of companies' initiatives for promoting the adoption of the RWE solution are further driving the market growth. However, the lack of universal acceptance for methodological standards and data processing infrastructure impedes the growth of the market over the forecast period of 2022-2028. Also, a growing focus on end-to-end RWE services is anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the Global Real World Evidence/RWE Solutions Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to increasing government initiatives for the adoption of RWE studies, coupled with the growing number of RWE service providers. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the presence of many Contract Research Organizations (CROs) and manufacturing companies, as well as growing demand for better healthcare services, would create lucrative growth prospects for the Real World Evidence/RWE Solutions Market across the Asia-Pacific region.

Major market players included in this report are:

Cognizant

Oracle

ICON, plc.

PAREXEL International Corporation

Cerner Corporation

Flatiron Health

PerkinElmer

Anthem

Cegedim Health Data

SAS

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Component

Services

Data Sets

Clinical Setting Data

Claims Data

Pharmacy Data

Patient Powered Data

By Therapeutic area

Oncology

Cardiovascular

Neurology

Immunology

Others

By End Users

Pharmaceutical and Medical Devices Companies

Healthcare Providers

Healthcare Payers

Other End Users

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Real World Evidence/RWE Solutions Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. Real World Evidence/RWE Solutions Market, by Region, 2020-2028 (USD Billion)

1.2.2. Real World Evidence/RWE Solutions Market, by Component, 2020-2028 (USD Billion)

1.2.3. Real World Evidence/RWE Solutions Market, by Therapeutic area, 2020-2028 (USD Billion)

1.2.4. Real World Evidence/RWE Solutions Market, by End Users, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Real World Evidence/RWE Solutions Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Real World Evidence/RWE Solutions Market Dynamics

3.1. Real World Evidence/RWE Solutions Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Increasing geriatric population and the subsequent increase in the prevalence of chronic diseases

3.1.1.2. Increasing support from the regulatory bodies for the adoption of RWE solutions

3.1.2. Market Challenges

3.1.2.1. Lack of universal acceptance for methodological standards and data processing infrastructure

3.1.3. Market Opportunities

3.1.3.1. Growing focus on end-to-end RWE services

Chapter 4. Global Real World Evidence/RWE Solutions Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Real World Evidence/RWE Solutions Market, by Component

6.1. Market Snapshot

6.2. Global Real World Evidence/RWE Solutions Market by Component, Performance - Potential Analysis

6.3. Global Real World Evidence/RWE Solutions Market Estimates & Forecasts by Component 2019-2028 (USD Billion)

6.4. Real World Evidence/RWE Solutions Market, Sub Segment Analysis

6.4.1. Services

6.4.2. Data Sets

6.4.3. Clinical Setting Data

6.4.4. Claims Sata

6.4.5. Pharmacy Data

6.4.6. Patient Powered Data

Chapter 7. Global Real World Evidence/RWE Solutions Market, by Therapeutic area

7.1. Market Snapshot

7.2. Global Real World Evidence/RWE Solutions Market by Therapeutic area, Performance - Potential Analysis

7.3. Global Real World Evidence/RWE Solutions Market Estimates & Forecasts by Therapeutic area 2019-2028 (USD Billion)

7.4. Real World Evidence/RWE Solutions Market, Sub Segment Analysis

7.4.1. Oncology

7.4.2. Cardiovascular

7.4.3. Neurology

7.4.4. Immunology

7.4.5. Others

Chapter 8. Global Real World Evidence/RWE Solutions Market, by End Users

8.1. Market Snapshot

8.2. Global Real World Evidence/RWE Solutions Market by End Users, Performance - Potential Analysis

8.3. Global Real World Evidence/RWE Solutions Market Estimates & Forecasts by End Users 2019-2028 (USD Billion)

8.4. Real World Evidence/RWE Solutions Market, Sub Segment Analysis

8.4.1. Pharmaceutical and Medical Devices Companies

8.4.2. Healthcare Providers

8.4.3. Healthcare Payers

8.4.4. Other End Users

Chapter 9. Global Real World Evidence/RWE Solutions Market, Regional Analysis

9.1. Real World Evidence/RWE Solutions Market, Regional Market Snapshot

9.2. North America Real World Evidence/RWE Solutions Market

9.2.1. U.S. Real World Evidence/RWE Solutions Market

9.2.1.1. Component estimates & forecasts, 2019-2028

9.2.1.2. Therapeutic area estimates & forecasts, 2019-2028

9.2.1.3. End Users estimates & forecasts, 2019-2028

9.2.2. Canada Real World Evidence/RWE Solutions Market

9.3. Europe Real World Evidence/RWE Solutions Market Snapshot

9.3.1. U.K. Real World Evidence/RWE Solutions Market

9.3.2. Germany Real World Evidence/RWE Solutions Market

9.3.3. France Real World Evidence/RWE Solutions Market

9.3.4. Spain Real World Evidence/RWE Solutions Market

9.3.5. Italy Real World Evidence/RWE Solutions Market

9.3.6. Rest of Europe Real World Evidence/RWE Solutions Market

9.4. Asia-Pacific Real World Evidence/RWE Solutions Market Snapshot

9.4.1. China Real World Evidence/RWE Solutions Market

9.4.2. India Real World Evidence/RWE Solutions Market

9.4.3. Japan Real World Evidence/RWE Solutions Market

9.4.4. Australia Real World Evidence/RWE Solutions Market

9.4.5. South Korea Real World Evidence/RWE Solutions Market

9.4.6. Rest of Asia Pacific Real World Evidence/RWE Solutions Market

9.5. Latin America Real World Evidence/RWE Solutions Market Snapshot

9.5.1. Brazil Real World Evidence/RWE Solutions Market

9.5.2. Mexico Real World Evidence/RWE Solutions Market

9.6. Rest of The World Real World Evidence/RWE Solutions Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Cognizant

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Oracle

10.2.3. ICON, plc.

10.2.4. PAREXEL International Corporation

10.2.5. Cerner Corporation

10.2.6. Flatiron Health

10.2.7. PerkinElmer

10.2.8. Anthem

10.2.9. Cegedim Health Data

10.2.10. SAS

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Real World Evidence/RWE Solutions Market, report scope

TABLE 2. Global Real World Evidence/RWE Solutions Market estimates & forecasts by Region 2019-2028 (USD Billion)

TABLE 3. Global Real World Evidence/RWE Solutions Market estimates & forecasts by Component 2019-2028 (USD Billion)

TABLE 4. Global Real World Evidence/RWE Solutions Market estimates & forecasts by Therapeutic area 2019-2028 (USD Billion)

TABLE 5. Global Real World Evidence/RWE Solutions Market estimates & forecasts by End Users 2019-2028 (USD Billion)

TABLE 6. Global Real World Evidence/RWE Solutions Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 7. Global Real World Evidence/RWE Solutions Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 8. Global Real World Evidence/RWE Solutions Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 9. Global Real World Evidence/RWE Solutions Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 10. Global Real World Evidence/RWE Solutions Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 11. Global Real World Evidence/RWE Solutions Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 12. Global Real World Evidence/RWE Solutions Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 13. Global Real World Evidence/RWE Solutions Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 14. Global Real World Evidence/RWE Solutions Market by segment, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 15. Global Real World Evidence/RWE Solutions Market by region, estimates & forecasts, 2019-2028 (USD Billion)

TABLE 16. U.S. Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 17. U.S. Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 18. U.S. Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 19. Canada Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 20. Canada Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 21. Canada Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 22. UK Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 23. UK Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 24. UK Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 25. Germany Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 26. Germany Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 27. Germany Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 28. RoE Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 29. RoE Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 30. RoE Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 31. China Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 32. China Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 33. China Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 34. India Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 35. India Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 36. India Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 37. Japan Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 38. Japan Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 39. Japan Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 40. RoAPAC Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 41. RoAPAC Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 42. RoAPAC Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 43. Brazil Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 44. Brazil Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 45. Brazil Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 46. Mexico Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 47. Mexico Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 48. Mexico Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 49. RoLA Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 50. RoLA Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 51. RoLA Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 52. Row Real World Evidence/RWE Solutions Market estimates & forecasts, 2019-2028 (USD Billion)

TABLE 53. Row Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 54. Row Real World Evidence/RWE Solutions Market estimates & forecasts by segment 2019-2028 (USD Billion)

TABLE 55. List of secondary sources, used in the study of Global Real World Evidence/RWE Solutions Market

TABLE 56. List of primary sources, used in the study of Global Real World Evidence/RWE Solutions Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research